RFA Plus Carrizumab vs Carrizumab Alone for HCC

NCT04150744 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Tumor Immunity
Immunosuppression
Radiofrequency Ablation

Interventions

COMBINATION_PRODUCT: radiofrequency ablation

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University